|
|
| | 17-Phenyl trinor-13,14-dihydro prostaglandin A2 Basic information |
| Product Name: | 17-Phenyl trinor-13,14-dihydro prostaglandin A2 | | Synonyms: | ZHCXQFHXZFWVRT-BRQXMNQMSA-N;9-OXO-15R-HYDROXY-17-PHENYL-18,19,20-TRINOR-PROSTA-5Z,10-DIEN-1-OIC ACID;13,14-dihydro-17-phenyl-18,19,20-trinor-PGA2;5-Heptenoic acid, 7-[2-(3-hydroxy-5-phenylpentyl)-5-oxo-3-cyclopenten-1-yl]-, [1R-[1α(Z),2β(R*)]]- (9CI);17-Phenyl trinor-13,14-dihydro prostaglandin A2 | | CAS: | 130209-80-2 | | MF: | C23H30O4 | | MW: | 370.48 | | EINECS: | | | Product Categories: | | | Mol File: | 130209-80-2.mol |  |
| | 17-Phenyl trinor-13,14-dihydro prostaglandin A2 Chemical Properties |
| solubility | DMF: >100 mg/ml (from Fluprostenol); DMSO: >100 mg/ml (from Fluprostenol); Ethanol: >100 mg/ml (from Fluprostenol); PBS pH 7.2: >0.8 mg/ml (from 17-phenyl tri |
| | 17-Phenyl trinor-13,14-dihydro prostaglandin A2 Usage And Synthesis |
| Description | 17-phenyl trinor-13,14-dihydro Prostaglandin A2 is a synthetic PG analog whose biological activity has not been widely reported. The PGF2α analog latanoprost, which bears the same lower side chain features, has been approved as a pharmaceutical for the treatment of glaucoma.1 | | Uses | 17-Phenyl trinor-13,14-dihydro prostaglandin A2 is a biochemical reagent. | | Definition | ChEBI: 17-phenyl trinor-13,14-dihydro Prostaglandin A2 is a prostanoid. | | References | 1. Alm, A., Villumsen, J., Trnquist, P., et al. Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study Ophthalmology 100,1312-1317(1993). |
| | 17-Phenyl trinor-13,14-dihydro prostaglandin A2 Preparation Products And Raw materials |
|